Skip to main content

Advertisement

SpringerLink
Log in

Relation Between Methylenetetrahydrofolate Reductase Polymorphisms (C677T and A1298C) and Migraine Susceptibility

  • Review Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Migraine is a neurological disorder which impairs the patient’s quality of life. Several association studies investigating the association between MTHFR gene C677T and A1298C polymorphisms and susceptibility to migraine were published. But the results were conflicting, so authors performed a meta-analysis of published case control studies to find out the exact association between MTHFR polymorphism and migraine susceptibility. Four databases were searched for suitable studies up to December, 2018. Odds ratios (OR) with 95% confidence intervals (CI) was calculated adopting additive, homozygote, co-dominant, dominant, and recessive genetic models. Results of MTHFR C677T polymorphism studies meta-analysis showed significant association with migraine risk using allele contrast, homozygote, dominant and recessive genetic models (T vs. C: OR = 1.18, 95% CI = 1.00–1.26, p = 0.05; TT vs. CC: OR = 1.24, 95% CI = 1.0–1.5, p = 0.04; CT vs. CC: OR = 1.08, 95% CI = 0.97–1.07, p = 0.25; TT + CT vs. CC: OR = 1.15, 95% CI = 1.0–1.29, p = 0.04; TT vs. CT + CC: OR = 1.97, 95% CI = 1.28–3.42, p = 0.002). However, results of MTHFR A1298 polymorphism studies meta-analysis did not show any association with migraine. Subgroup analysis based on ethnicity and migraine types i.e. migraine with aura (MA) and without aura (MO) were also performed. Results of present meta-analysis indicate overall association between MTHFR C677T polymorphism with migraine in total 24 studies, in Asian population and in MA cases but did not show any association with Caucasian population and MO cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 2006;5:148–57.

    PubMed  PubMed Central  Google Scholar 

  2. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004;24(Suppl 1):9–160.

  3. Montagna P. Molecular genetics of migraine headaches: a review. Cephalalgia. 2000;20(1):3–14.

    CAS  PubMed  Google Scholar 

  4. Wessman M, Terwindt GM, Kaunisto MA, Palotie A, Ophoff RA. Migraine: a complex genetic disorder. Lancet Neurol. 2007;6(6):521–32.

    CAS  PubMed  Google Scholar 

  5. Bille B. A 40-year follow-up of school children with migraine. Cephalalgia. 1997;17(4):488–91.

    CAS  PubMed  Google Scholar 

  6. Mulder EJ, van Baal C, Gaist D, Kallela M, Kaprio J, Svensson DA, Nyholt DR, Martin NG, MacGregor AJ, Cherkas LF, Boomsma DI, Palotie A. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res. 2003;6(5):422–31.

    PubMed  Google Scholar 

  7. Svensson DA, Larsson B, Waldenlind E, Pedersen. Shared rearing environment in migraine: results from twins reared apart and twins reared together. Headache. 2003;43(3):235–44.

  8. Nyholt DR, Gillespie NG, Heath AC, Merikangas KR, Duffy DL, Martin NG. Latent class and genetic analysis does not support migraine with aura and migraine without aura as separate entities. Genet Epidemiol. 2004;26(3):231–44.

    PubMed  Google Scholar 

  9. Ligthart L, Boomsma DI, Martin NG, Stubbe JH, Nyholt DR. Migraine with aura and migraine without aura are not distinct entities: further evidence from a large Dutch population study. Twin Res Hum Genet. 2006;9(1):54–63.

    PubMed  Google Scholar 

  10. Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Renlund M, et al. Geographical and ethnic variation of the 677C>T allele of 5,10-methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas worldwide. J Med Genet. 2003;40:619–25.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Rai V, Yadav U, Kumar P, Yadav SK. Methyleletetrahydrofolate reductase polymorphism (C677T) in Muslim population of Eastern Uttar Pradesh. India Ind J Med Sci. 2010;64(5):219–23.

    Google Scholar 

  12. Rai V, Yadav U, Kumar P. Genotype prevalence and allele frequencies of 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T mutation in two caste groups of India. Cell Mol Biol. 2012;58:OL1695-701.

  13. Yadav U, Kumar P, Gupta S, Rai V. Distribution of MTHFR C677T gene polymorphism in healthy North Indian population and an updated meta-analysis. Ind J Clin Biochem. 2017;32(4):399–410.

    CAS  Google Scholar 

  14. Weisberg P, Tran B, Christensen S, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64:169–72.

    CAS  PubMed  Google Scholar 

  15. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151:862–77.

    CAS  PubMed  Google Scholar 

  16. Robien K, Ulrich CM. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE mini-review. Am J Epidemiol. 2003;157:571–82.

    PubMed  Google Scholar 

  17. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111–3.

    CAS  PubMed  Google Scholar 

  18. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7–9.

    CAS  PubMed  Google Scholar 

  19. Liu ZZ, Zhang JT, Liu D, Hao YH, Chang BM, Xie J, Li PZ. Interaction between maternal 5, 10-methylenetetrahydrofolate reductase C677T and methionine synthase A2756G gene variants to increase the risk of fetal neural tube defects in a Shanxi Han population. Chin Med J (Engl). 2013;126(5):865–9.

    CAS  Google Scholar 

  20. Elsayed GM, Elsayed SM, Ezz-Elarab SS. Maternal MTHFR C677T genotype and septal defects in offspring with Down syndrome: A pilot study. Egypt J Med Hum Genet. 2013;15(1):39–44.

    Google Scholar 

  21. Mansouri L, Fekih-Mrissa N, Klai S, Mansour M, Gritli N, Mrissa R. Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer’s disease. Clin Neurol Neurosurg. 2013;115:1693–6.

    PubMed  Google Scholar 

  22. Białecka M, Kurzawski M, Roszmann A, Robowski P, Sitek EJ, Honczarenko K, et al. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson’s disease. Pharmacogenet Genomics. 2012;22:716–24.

    PubMed  Google Scholar 

  23. Nishi A, Numata S, Tajima A, Kinoshita A, Kikuchi K, Shimodera S, et al. Meta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophrenia. Schizophr Bul. 2014;40(5):1154–63.

    Google Scholar 

  24. Shawky RM, El-baz F, T Kamal TM, Elhossiny RM, Ahmed MA, El Nady GH. Study of genotype–phenotype correlation of methylene tetrahydrofolate reductase (MTHFR) gene polymorphisms in a sample of Egyptian autistic children. Egypt J Med Hum Genet. 2014;15:335–41.

  25. Prasad AN, Rupar CA, Prasad C. Methylenetetrahydrofolate reductase (MTHFR) deficiency and infantile epilepsy. Brain Dev. 2011;33:758–69.

    PubMed  Google Scholar 

  26. Azimova JE, Sergeev AV, Korobeynikova LA, Kondratieva1 NS, Kokaeva ZG, Shaikhaev GO, Skorobogatykh KV, Fokina NM, Tabeeva GR, Klimov EA. Effects of MTHFR gene polymorphism on the clinical and electrophysiological characteristics of migraine. BMC Neurol. 2013;13:103–9.

  27. Bahadir A, Eroz R, Dikici S. Investigation of MTHFR C677T gene polymorphism, biochemical and clinical parameters in Turkish migraine patients: association with allodynia and fatigue. Cell Mol Neurobiol. 2013;33:1055–63.

    CAS  PubMed  Google Scholar 

  28. Kaunisto M, Kallela M, Hamalainen E, Kilpikari R, Havanka H, Harno H, Nissila M, Sako E, Ilmavirta M, Liukkonen J, Teirmaa H, Tornwall O, Jussila M, Terwilliger J, Farkkila M, Kaprio J, Palotie A, Wessman M. Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia. 2006;26(12):1462–72.

    CAS  PubMed  Google Scholar 

  29. Ishii M, Shimizu S, Sakairi Y, Nagamine A, Naito Y, Hosaka Y, Naito Y, Kurihara T, Onaya T, Oyamada H, Imagawa A, Shida K, Takahashi J, Oguchi K, Masuda Y, Hara H, Usami S, Kiuchi Y. MAOA, MTHFR, and TNF-beta genes polymorphisms and personality traits in the pathogenesis of migraine. Mol Cell Biochem. 2012;363(1–2):357–66.

    CAS  PubMed  Google Scholar 

  30. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15) 2008–12.

  31. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.

    CAS  PubMed  Google Scholar 

  32. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controll Clin Trials. 1986;7:177–88.

    CAS  Google Scholar 

  33. Zintzaras E, Ioannidis JP. HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics. 2005;21(18):3672–3.

    CAS  PubMed  Google Scholar 

  34. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

    PubMed  Google Scholar 

  35. Zintzaras E. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatr Genet. 2006;16(3):105–15.

    PubMed  Google Scholar 

  36. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Wallace BC, Dahabreh IJ, Trikalinos TA, Lau J, Trow P, Schmid CH. Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Softw. 2013;49:1–15.

    Google Scholar 

  38. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol. 2006;6:50–8.

    PubMed  PubMed Central  Google Scholar 

  39. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet. 2000;96(6):762–4.

    CAS  PubMed  Google Scholar 

  40. Kara I, Sazci A, Ergul E, Kaya G, Kilic G. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res. 2003;111(1–2):84–90.

    CAS  PubMed  Google Scholar 

  41. Lea R, Ovcaric M, Sundholm J, MacMillan J, Griffiths L. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med. 2004;2(1):3.

    PubMed  PubMed Central  Google Scholar 

  42. Oterino A, Valle N, Bravo Y, Munoz P, Sanchez-Velasco P, Ruiz-Alegria C, Castillo J, Leyva-Cobian F, Vadillo A, Pascual J. MTHFR T677 homozygosis influences the presence of aura in migraineurs. Cephalalgia. 2004;24(6):491–4.

    CAS  PubMed  Google Scholar 

  43. Oterino A, Valle N, Pascual J, Bravo Y, Munoz P, Castillo J, Ruiz-Alegria C, Sanchez-Velasco P, Leyva-Cobian F, Cid C. Thymidylate synthase promoter tandem repeat and MTHFD1 R653Q polymorphisms modulate the risk for migraine conferred by the MTHFR T677 allele. Mol Brain Res. 2005;139(1):163–8.

    CAS  PubMed  Google Scholar 

  44. Scher AI, Terwindt GM, Verschuren WMM, Kruit MC, Blom HJ, Kowa H, Frants RR, van den Maagdenberg AMJM, van Buchem M, Ferrari MD, Launer LJ. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol. 2006;59(2):372–5.

    CAS  PubMed  Google Scholar 

  45. Todt U, Freudenberg J, Goebel I, Netzer C, Heinze A, Heinze-Kuhn K, Göbel H, Kubisch C. MTHFR C677T polymorphism and migraine with aura. Ann Neurol. 2006;60(5):621–2.

    PubMed  Google Scholar 

  46. Bottini F, Celle M, Calevo M, Amato S, Minniti G, Montaldi L, Pasquale DD, Cerone R, Veneselli E, Molinari A. Metabolic and genetic risk factors for migraine in children. Cephalalgia. 2006;26(6):731–7.

    CAS  PubMed  Google Scholar 

  47. Pezzini A, Grassi M, Del Zotto E, Giossi A, Monastero R, Dalla Volta G, Archetti S, Zavarise P, Camarda C, Gasparotti R, Magoni M, Camarda R, Padovani A. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke. 2007;38(12):3145–51.

    CAS  PubMed  Google Scholar 

  48. Schurks M, Zee RYL, Buring JE, Kurth T. Interrelationships among the MTHFR 677C > T polymorphism, migraine, and cardiovascular disease. Neurology. 2008;71(7):505–13.

    PubMed  Google Scholar 

  49. Ferro A, Castro MJ, Lemos C, Santos M, Sousa A, Pereira-Monteiro J, Sequeiros J, Maciel P. The C677T polymorphism in MTHFR is not associated with migraine in Portugal. Dis Mark. 2008;25(2):107–13.

    CAS  Google Scholar 

  50. Joshi G, Pradhan S, Mittal B. Role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population. J Neurol Sci. 2009;277(1–2):133–7.

    CAS  PubMed  Google Scholar 

  51. Oterino A, Toriello M, Valle N, Castillo J, Alonso-Arranz A, Bravo Y, Ruiz-Alegria C, Quintela E, Pascual J. The relationship between homocysteine and genes of folate-related enzymes in migraine patients. Headache. 2010;50(1):99–168.

    PubMed  Google Scholar 

  52. Schurks M, Rist PM, Kurth T. MTHFR 677C>T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis. Headache. 2010;50(4):588–99.

    PubMed  Google Scholar 

  53. Samaan Z, Gaysina D, Cohen-Woods S, Craddock N, Jones L, Korszun A, Owen M, Mente A, McGuffin P, Farme A. Methylenetetrahydrofolate reductase gene variant (MTHFR C677T) and migraine: a case control study and meta-analysis. BMC Neurol. 2011;11:66.

    PubMed  PubMed Central  Google Scholar 

  54. An XK, Lu CX, Ma QL, Zhang XR, Burgunder JM, Lin Q, Qu HL. Association of MTHFR C677T polymorphism with susceptibility to migraine in the Chinese population. Neurosci Lett. 2013;549:78–81.

    CAS  PubMed  Google Scholar 

  55. Scher AI, Eiriksdottir G, GarciaM, Feit P, Smith AV, Harris TB, et al. Lack of association between the MTHFR C677T variant and migraine with aura in an older population: could selective survival play a role? Cephalalgia. 2013;33(5):308–15.

  56. Essmeister R, Kress HG, Zierz S, Griffith L, Lea R, Wieser T. MTHFR and ACE polymorphisms do not increase susceptibility to migraine neither alone nor in combination. Headache. 2016;56(8):1267–73.

    PubMed  Google Scholar 

  57. Kaur S, Ali A, Pandey AK, Singh B. Association of MTHFR gene polymorphisms with migraine in North Indian population. Neurol Sci. 2018. https://doi.org/10.1007/s10072-018-3276-7.

    Article  PubMed  Google Scholar 

  58. Salehi M, Amin-Beidokhti M, Safarpour Lima B, Gholami M, Javadi GR, Mirfakhraie R. The rs4846049 polymorphism in the 3’UTR region of the MTHFR gene increases the migraine susceptibility in an Iranian population. J Pain Res. 2018;11:145–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Zintzaras E, Sakelaridis N. Is 472G/A catechol-O-methyl-transferase gene polymorphism related to panic disorder? Psychiatr Genet. 2007;17(5):267–73.

    PubMed  Google Scholar 

  60. Tietjen GE. Migraine as a systemic disorder. Neurology. 2007;68:1555–6.

    PubMed  Google Scholar 

  61. Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology. 2007;68:1563–70.

    PubMed  Google Scholar 

  62. Buemi M, Marino D, Di Pasquale G, Floccari F, Ruello A, Aloisi C, Corica F, Senatore M, Romeo A, Frisina N. Effects of homocysteine on proliferation, necrosis, and apoptosis of vascular smooth muscle cells in culture and influence of folic acid. Thromb Res. 2001;104(3):207–13.

    CAS  PubMed  Google Scholar 

  63. Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer’s disease. J Neurosci. 2002;22(5):1752–62.

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Parsons AA, Strijbos PJ. The neuronal versus vascular hypothesis of migraine and cortical spreading depression. Curr Opin Pharmacol. 2003;3(1):73–7.

    CAS  PubMed  Google Scholar 

  65. Zieminska E, Lazarewicz JW. Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: the role of NMDA and group I metabotropic glutamate receptors. Acta Neurobiol Exp (Wars). 2006;66(4):301–9.

    Google Scholar 

  66. Tzourio C, El Amrani M, Poirier O, Nicaud V, Bousser MG, Alperovitch A. Association between migraine and endothelin type A receptor (ETA-231 A/G) gene polymorphism. Neurology. 2001;22(56(10)):1273–7.

  67. Rai V. Polymorphism in folate metabolic pathway gene as maternal risk factor for Down syndrome. Int J Biol Med Res. 2011;2(4):1055–60.

    Google Scholar 

  68. Rai V, Kumar P. Fetal MTHFR C677T polymorphism confers no susceptibility to Down syndrome: evidence from meta-analysis. Egypt J Med Hum Genet. 2018;19:53–8.

    Google Scholar 

  69. Rai V. Evaluation of methylenetetrahydrofolate reductase gene variant (C677T) as risk factor for bipolar disorder. Cell Mol Biol. 2011;57:1558–66.

    Google Scholar 

  70. Rai V. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene and susceptibility to depression in Asian population: a systematic meta-analysis. Cell Mol Biol. 2014;60(3):29–36.

    CAS  PubMed  Google Scholar 

  71. Rai V. Maternal methylenetetrahydrofolate reductase (MTHFR) gene A1298C polymorphism and risk of nonsyndromic Cleft lip and/or Palate (NSCL/P) in offspring: a meta-analysis. Asian J Med Sci. 2014;6(1):16–21.

    Google Scholar 

  72. Rai V. Strong association of C677T polymorphism of methylenetetrahydrofolate reductase gene with nosyndromic cleft lip/palate (nsCL/P). Ind J Clin Biochem. 2017;33(1):5–15.

    Google Scholar 

  73. Rai V. Methylenetetrahydrofolate reductase gene A1298C polymorphism and susceptibility to recurrent pregnancy loss: a meta-analysis. Cell Mol Biol. 2014;60(2):27–34.

    CAS  PubMed  Google Scholar 

  74. Rai V. Methylenetetrahydrofolate reductase C677T polymorphism and recurrent pregnancy loss risk in Asian population: a meta-analysis. Ind J Clin Biochem. 2016;31:402–13.

    CAS  Google Scholar 

  75. Rai V. Association of C677T polymorphism (rs1801133) in MTHFR gene with depression. Cell Mol Biol. 2017;63(6):60–7.

    CAS  PubMed  Google Scholar 

  76. Rai V. The MTHFR C677T polymorphism and hyperuricemia risk: a meta-analysis of 558 cases and 912 controls. Metabolomics. 2016;6(166):2153–769.

    Google Scholar 

  77. Rai V. Association of methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism with autism: evidence of genetic susceptibility. Metab Brain Dis. 2016;31:727–35.

    CAS  PubMed  Google Scholar 

  78. Rai V, Kumar P. Methylenetetrahydrofolatereductase A1298C Polymorphism and Autism susceptibility. Austin J Autism Relat Disabil. 2018;4:1048–53.

    Google Scholar 

  79. Rai V. Methylenetetrahydrofolate reductase Gene C677T polymorphism and its association with Ovary cancer. J Health Med Inform. 2016;7:3.

    Google Scholar 

  80. Rai V. Evaluation of the MTHFR C677T polymorphism as a risk factor for colorectal cancer in Asian populations. Asian Pac J Cancer Prev. 2016;16(18):8093–100.

    Google Scholar 

  81. Rai V. Folate pathway gene methylenetetrahydrofolate reductase C677T polymorphism and Alzheimer disease risk in Asian population. Indian J Clin Biochem. 2016;31(3):245–52.

    CAS  PubMed  Google Scholar 

  82. Rai V. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and Alzheimer disease risk: a meta-analysis. Mol Neurobiol. 2017;54:1173–86.

    CAS  PubMed  Google Scholar 

  83. Rai V, Yadav U, Kumar P. Impact of Catechol-O-methyltransferase Val 158Met (rs4680) polymorphism on breast cancer susceptibility in Asian population. Asian Pac J Cancer Prev. 2017;18(5):1243–50.

    PubMed  PubMed Central  Google Scholar 

  84. Rai V, Kumar P. Methylenetetrahydrofolate reductase C677T polymorphism and risk of male infertility in Asian population. Ind J Clin Biochem. 2017;32(3):253–226.

    CAS  Google Scholar 

  85. Rai V, Yadav U, Kumar P, Yadav SK, Gupta S. Methylenetetrahydrofolate reductase A1298C genetic variant and risk of schizophrenia: an updated meta-analysis. Indian J Med Res. 2017;145(4):437.

    CAS  PubMed  PubMed Central  Google Scholar 

  86. Kumar P, Singh G, Rai V. Evaluation of COMT gene rs4680 polymorphism as a risk factor for endometrial cancer. Ind J Clin Biochem. 2018. https://doi.org/10.1007/s12291-018-0799-x.

    Article  Google Scholar 

  87. Rai V, Kumar P. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy. Neurol Sci. 2018. https://doi.org/10.1007/s10072-018-3583-z.

    Article  PubMed  Google Scholar 

  88. Kumar P, Rai V. Catechol-O-Methyltransferase Val158Met polymorphism and susceptibility to Uterine Leiomyoma. Jacobs J Gynecol Obstet. 2018;5(1):043.

    Google Scholar 

  89. Kumar P, Rai V. MTHFR C677T polymorphism and risk of esophageal cancer: an updated meta-analysis. Egypt J Med Hum Genet. 2018;19:273–84.

    Google Scholar 

  90. Kumar P, Rai V. Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: a meta-analysis. Metab Brain Dis. 2020;35(2):241–51.

    CAS  PubMed  Google Scholar 

  91. Rai V. MethylenetetrahydrofolateReductase (MTHFR) A1298C polymorphism and risk of lung cancer. Austin Hepatol. 2020;5(1):1011.

    Google Scholar 

  92. Liu R, Geng P, Ma M, Yu S, Yang M, He M, Dong Z, Zhang W. MTHFR C677T polymorphism and migraine risk: a meta-analysis. J Neurol Sci. 2014;336:68–73.

    CAS  PubMed  Google Scholar 

  93. Rbino E, Ferrero M, Rainero I, Binello E, Vaula G, Pinessi L. Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis. Cephalalgia. 2009;29(8):818–25.

    Google Scholar 

Download references

Funding

Nil.

Author information

Authors and Affiliations

  1. Human Molecular Genetics Laboratory, Department of Biotechnology, VBS Purvanchal University, Jaunpur, UP, 222 003, India

    Vandana Rai & Pradeep Kumar

Authors
  1. Vandana Rai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pradeep Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vandana Rai.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

Present manuscript is a meta-analysis/review, hence, ethical clearance is not required for the present manuscript, no human blood/ tissue samples are used in the present manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rai, V., Kumar, P. Relation Between Methylenetetrahydrofolate Reductase Polymorphisms (C677T and A1298C) and Migraine Susceptibility. Ind J Clin Biochem 37, 3–17 (2022). https://doi.org/10.1007/s12291-021-01000-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-021-01000-0

Keywords

Search

Navigation